within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H03B_AntithyroidPreparations.H03BB02_Thiamazole;

model Thiamazole
  extends Pharmacolibrary.Drugs.ATC.H.H03BB02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>H03BB02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Thiamazole (also known as methimazole) is an antithyroid medication primarily used in the treatment of hyperthyroidism, including Graves' disease. It works by inhibiting the synthesis of thyroid hormones. Methimazole is approved and commonly used in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Reported pharmacokinetic parameters in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Skellern, GG, et al., &amp; Alexander, WD (1980). The pharmacokinetics of methimazole in pregnant patients after oral administration of carbimazole. <i>British journal of clinical pharmacology</i> 9(2) 145–147. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1980.tb05824.x&quot;>10.1111/j.1365-2125.1980.tb05824.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7356901/&quot;>https://pubmed.ncbi.nlm.nih.gov/7356901</a></p></li><li><p>Skellern, GG, et al., &amp; Kalk, WJ (1980). The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients. <i>British journal of clinical pharmacology</i> 9(2) 137–143. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1980.tb05823.x&quot;>10.1111/j.1365-2125.1980.tb05823.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7356900/&quot;>https://pubmed.ncbi.nlm.nih.gov/7356900</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Thiamazole;
